News

Smartphone app can pick up covert hepatic encephalopathy


 

FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

References

Researchers have road-tested an app based on the Stroop test, which is designed to detect covert hepatic encephalopathy, with results suggesting it achieves results similar to those of a paper-based Stroop test.

The smartphone-based EncephalApp was tested in 167 patients with cirrhosis and 114 healthy age-matched controls, and showed significant correlation with individual paper/pen test and with crashes and illegal turns in driving simulation tests, as well as high test/retest reliability at 1 and 3 months.

The study also found that patients with prior overt hepatic encephalopathy had significantly worse response times with the EncephalApp compared to controls (Clin Gastroenterol Hepatol. 2015;13:1828-35).

Dr. Jasmohan S. Bajaj

Dr. Jasmohan S. Bajaj

“Although these [gold standard paper-pencil] measures are used to diagnose CHE [covert hepatic encephalopathy] in research studies, they have not found traction in clinical practice because of their copyrighted nature, need for psychological expertise, and time requirements,” wrote Dr. Jasmohan S. Bajaj of Virginia Commonwealth University and McGuire VA Hospital, both in Richmond, Va.

“Our results are in sync with the prior experience with the old Stroop App in that in similar prior HE [hepatic encephalopathy] studies, we found that the psychomotor function, i.e., the time required to complete tasks, was much more predictive than the errors committed (number of runs required) and the cognitive flexibility measures (OnTime-OffTime) in differentiating groups,” wrote Dr. Bajaj and colleagues.

The National Institute of Diabetes and Digestive and Kidney Diseases, the National Center for Advancing Translational Research and the McGuire Research Institute funded the study. There were no other conflicts of interest declared.

Recommended Reading

Inpatient mortality down for high-volume conditions
MDedge Internal Medicine
Unvetted drug indications mean safety uncertainties
MDedge Internal Medicine
AAIC: Proving drugs modify Alzheimer’s disease faces skepticism
MDedge Internal Medicine
EEG detects early conversion to Alzheimer’s disease
MDedge Internal Medicine
Sexual abuse history may promote migraine transformation
MDedge Internal Medicine
Alzheimer’s patients often had low cerebral amyloid
MDedge Internal Medicine
Physical activity, omega-3 supplements didn’t improve cognitive outcomes
MDedge Internal Medicine
Breastfeeding protects against postpartum MS relapse
MDedge Internal Medicine
VIDEO: Use fiduciary duty to set pain medication boundaries
MDedge Internal Medicine
VIDEO: Consistency is key to monitoring patients on opioids
MDedge Internal Medicine